GLP Identity Tests and Nano-Test Solutions for Pharmaceutical Products
In the pharmaceutical industry, patient safety and product quality are undoubtedly the two most important factors. A drug must be tested before it is launched on the market and at every stage of the manufacturing process. This is precisely where GLP identity testing for pharmaceutical products comes into play. Good Laboratory Practice (GLP) is a quality system that ensures these tests are conducted reliably, reproducibly, and in accordance with international standards.
The “identity” of a pharmaceutical product refers to its molecular structure, chemical formula, and physical properties. The use of an incorrect raw material or cross-contamination on the production line can lead to irreparable consequences. Therefore, the identity tests conducted under GLP serve to analytically verify that the product is indeed the “intended active ingredient.”
The Importance of Identity Testing for Pharmaceutical Products
Identity testing is not only an analytical process but also a legal requirement. Regulatory agencies such as the FDA, the EMA, and the TİTCK require proof, in connection with marketing authorization applications and as part of routine quality control, that these tests were conducted in accordance with GLP principles. Without identity testing, a product cannot be released.
GLP standards establish strict requirements in areas such as staff training, equipment calibration, standard operating procedures (SOPs), and data integrity. As a result, the results obtained are recognized internationally. These tests also play an important role in combating counterfeit drugs and ensuring supply chain security.
Basic Analytical Methods within the Framework of GLP
Several analytical techniques can be combined to identify a pharmaceutical product or an active pharmaceutical ingredient (API). The choice of method depends on the structure of the molecule and the relevant pharmacopoeia monograph (e.g., USP, European Pharmacopoeia).
1. Spectroscopic Methods
- Fourier-transform infrared spectroscopy (FTIR): Considered the “fingerprint” of a molecule. By analyzing the vibrational bands of the functional groups, it is confirmed that the substance is identical to the standard reference material.
- UV-Vis Spectrophotometry: Specifically measures the absorption of molecules containing chromophore groups at certain wavelengths. Ideal for rapid screening.
- Nuclear Magnetic Resonance (NMR): The most powerful technique for determining molecular structure. It is used in GLP studies, particularly for the verification of complex molecules.
2. Chromatographic Methods
- High-Performance Liquid Chromatography (HPLC): Identification is typically performed by comparing retention times.
- Thin-layer chromatography (TLC): It is a cost-effective and efficient method, particularly for identifying plant-based products and certain excipients.
3. Thermal Analysis and Other Topics
- Differential Scanning Calorimetry (DSC): It is of crucial importance in the analysis of polymorphs (different crystal structures of the same molecule).
Comparison of Methods Used in GLP Identity Tests
The following table summarizes the basic characteristics of the methods most commonly used in GLP identity testing for drugs:
| Analytical Method | Measurement Principle | Advantages | Typical Applications |
|---|---|---|---|
| FTIR | Molecular Vibrational Bands | Fast, non-destructive, high specificity | Verification of Raw Materials and Finished Products |
| HPLC | Chromatographic Separation + Detector | High sensitivity, combinable with quantification | Determination of the Purity and Identity of Active Ingredients |
| DSC | Heat Flow Difference (Melting/Crystallization) | Detection of Polymorphic and Amorphous Structures | Solid dosage forms, physical stability |
| NMR | Magnetic Resonance of Atomic Nuclei | Precise structural determination, versatility | Unidentified impurities, registration of new molecules |
GLP-Compliant Identity Testing with Nano-Test
Given the increasing pace of drug development, the primary goal is to ensure that no compromises are made regarding the accuracy of analytical results. With its advanced technological infrastructure and highly qualified staff, Nano-Test stands out as a reliable partner for GLP-compliant identity testing in the pharmaceutical industry.
Nano-Test – Statement of Work
Nano-Test provides its services in laboratories equipped with state-of-the-art analytical instruments that are fully compliant with Good Laboratory Practice (GLP) standards and the ISO/IEC 17025 standard. Our service portfolio includes identity testing in accordance with all pharmacopoeia monographs, including FTIR, HPLC, GC-MS, LC-MS/MS, DSC, and NMR.
At Nano-Test, we don’t just provide an analysis result—we deliver a complete GLP-compliant report that ensures data integrity (ALCOA+ principles), includes an audit trail, and is recognized by international regulatory authorities. Verify your product identity throughout your entire supply chain—from raw material incoming inspection to final product release testing—with the Nano-Test Guarantee.
Why Nano-Test?
- Fast Turnaround: Automated sample preparation systems reduce standard analysis times.
- Expert Team: Chemists and pharmacists with over 15 years of experience in pharmaceutical analysis.
- Regulatory Compliance: Full compliance with current ICH, USP, EP, and FDA guidelines.
Result
The safety of a pharmaceutical product begins with its correct identification. GLP-compliant pharmaceutical identity testing provides scientific evidence that the product is the molecule specified in the formulation. Incorrect identification can result in recall costs running into the millions and endanger patient health. At a time when regulations are becoming stricter by the day, partnering with a reliable and fully GLP-compliant provider like Nano-Test is the most sensible way to protect your brand’s reputation and public health.